Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 932-938

  Caudle, Abigail S ^a   Gonzalez Angulo, Ana M ^a   Hunt, Kelly K ^a   Pusztai, Lajos ^a   Kuerer, Henry M ^a   Mittendorf, Elizabeth A ^a   Hortobagyi, Gabriel N ^a   Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURGERY; FEMALE; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; SKIN FLAP; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955840128     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1390-8     Document Type: Article

References (15)

1. Hunt K, Yi M, Mittendorf E, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009.
2. Eisenhauer E, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47.
3. Caudle A, Gonzalez-Angulo A, Hunt K, et al. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28:1821-28.
4. Fisher B, Bryant J, Wolmark N, et al. Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672-85. (Pubitemid 28363030)
5. van Nes J, Putter H, Julien J, et al. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902. Breast Cancer Res Treat. 2009;115:101-13.
6. Bear H, Anderson S, Smith R, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2006;24:2019-27. (Pubitemid 46622110)
7. van der Hage J, van de Velde C, Julien J, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol. 2002;20:2905-6.
8. Boughey J, Peintinger F, Meric-Bernstam F, et al. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006;244: 464-70.
9. Taylor M, Perez C, Halverson K, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:753-64.
10. Christy C, Thorsteinsson D, Grube B, et al. Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter. Ann Surg Oncol. 2009;16: 697-702.
11. Shen J, Valero V, Buchholz T, et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol. 2004;11:854-60.
12. Chagpar A, Middleton L, Sahin A, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006;243:257-64. (Pubitemid 43185446)
13. Boughey J, Wagner J, Garrett B, et al. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol. 2009;16:1606-11.
14. Faneyte I, Schrama J, Peterse J, et al. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. Br J Cancer. 2003;88:406-12. (Pubitemid 36308152)
15. Dowsett M, Dunbier A. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast canc. Clin Cancer Res. 2008;14:8019-26.